Legal Representation
Attorney
Arthur Schwartz
USPTO Deadlines
Next Deadline
2033 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2011-02-15)
Due Date
February 15, 2031
Grace Period Ends
August 15, 2031
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 22, 2017 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
| Feb 15, 2011 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 30, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 30, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 25, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 25, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 12, 2010 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 12, 2010 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Oct 12, 2010 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 12, 2010 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 12, 2010 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 12, 2010 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 12, 2010 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 1, 2010 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 1, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 1, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 6, 2010 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 6, 2010 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 5, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 30, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 29, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Additional Information
Color Claim
Color is not claimed as a feature of the mark.